How compliant is your marketing, really?

Paste your practice website. Get a live compliance score in seconds.

Built on FDA and FTC enforcement patterns in regenerative medicine marketing.

start here

✓ See your score instantly -- no email, no signup

This just scans your site's public pages. No personal info is submitted until you choose to enter it below.

400+
FDA warning letters sent to stem cell providers since 2018
4x
Growth in unapproved clinics between 2016 and 2021, oversight hasn't kept pace
$3.31M
Judgment against a clinic for deceptive stem cell marketing claims, FTC's first case of its kind

Your license is what's actually on the line here!!

Regulators don't send a warning before the warning letter.

Every week your site stays unreviewed is another week of exposure.

--
/ 100
Compliance risk -- higher score means lower risk
0 -- High risk 55 80 100 -- Low risk
↓
Get your full report

Enter your info below. Your full report, including exactly which pages and claims are driving your score, goes to your email.

This report is yours whether you work with us or not. If it leads to us working together, good. If not, you still know exactly where your risk is.

Your report is emailed to you and kept on file so we can follow up if you want help. It isn't shared with anyone else, including regulators.

What happens next: your report by email, one call from us to walk through it. No sequence, no spam. Opt out any time.

What this checks

Your site is scanned against six categories FDA and FTC have cited in real enforcement actions against regenerative medicine practices, plus federal disclosure requirements for regenerative treatment marketing.

01Disease and condition claims✓
02Mechanism-of-action language✓
03Outcome guarantees✓
04Comparative superiority claims✓
05Unauthorized FDA approval claims✓
06Unsubstantiated proof language✓

Why this matters now

FDA and FTC enforcement against stem cell and exosome marketing has increased steadily. A warning letter does not start with a lawsuit. It starts with marketing language someone flagged. Most practices never see the letter coming, because the language that triggers it usually reads as ordinary marketing copy, not as a claim.

Karlista Maroney speaking to physicians

Built by Karlista Maroney, founder of DIGICO and physician marketing strategist who's worked with 30+ regenerative medicine physicians and spoken to 600+ doctors on patient trust and communication.